Global stem cell therapy market share by type forecast 2029

Published by
Matej Mikulic,
Feb 21, 2025
The total global stem cell therapy market was valued at around 755 million U.S. dollars in 2018, and it is projected to reach around 11 billion dollars by 2029. Stem cell therapies are mostly distributed into two types: autologous treatment (treatment with patient’s own stem cells) and allogenic treatment (treatment with donor’s stem cells). The market share of autologous treatments is expected to drop from 56 to some 36 percent from 2018 to 2029.

Global stem cell therapy market share in 2018 and a forecast for 2029, by treatment type*

CharacteristicAllogenicAutologous
2029 64.5% 35.5%
2018 44% 56%
Showing entries 1 to 2 (2 entries in total)
Created with Highcharts 7.2.2Market share44%44%64.5%64.5%56%56%35.5%35.5%AllogenicAutologous20182029
0%20%40%60%80%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2019

Region

Worldwide

Survey time period

as of 2019

Supplementary notes

* All figures are rounded; the 2029 values are projected.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on " Cell and gene therapy "

Other statistics that may interest you Cell and gene therapy

Market overview

6

R&D/trials

5

Stem cells

5

Cord blood

5

CAR/CAR-T

4

Miscellaneous

5

Further related statistics

9

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

Animal testingGlobal pharmaceutical industryPharmaceutical industry in the U.S.Pharmaceutical industry in the UKAnimal health in the U.S.
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.